Helio Genomics and Quest Diagnostics have partnered to expand access to a blood-based liver cancer test across the U.S. Starting in April, providers with a Quest account will be able to order HelioLiver, a test designed for early detection of hepatocellular carcinoma, through Quest’s network,…
The 2025 Identity Theft Resource Center report confirms what many physician-owners are feeling: cyberattacks are no longer random — they’re…
UMass’ Division of Gastroenterology has completed its first Full-Thickness Resection Device (FTRD) procedure, marking an expansion in advanced endoscopic capabilities.…
Austin Gastroenterology will open a new South Austin location on March 2, consolidating its former James Casey and Southwest clinics…
The Medicare Payment Advisory Commission (MedPAC) has voted to acknowledge what many physician groups have warned for years: Medicare physician…
DDW 2025
A new DDW 2025 study reveals a surprising truth: most post-polypectomy colorectal…
With 19 million more patients now eligible for colorectal cancer screening, the…
Headlines in GI
Helio Genomics and Quest Diagnostics have partnered to expand access to a…
A growing consensus is emerging among obesity experts: the healthcare system—not the…
Thought Leadership
GI surgery is undergoing a fundamental shift—from an art shaped by experience and intuition to a data-driven, digitally quantified discipline. Historically, surgical mastery relied…
In this expert discussion on the Gastroenterology Learning Network, Megan Riehl and…
We have all seen the unfortunate headlines. Why are we seeing a…
A new generation of multi-cancer early detection (MCED) blood tests promises to…
ARTIFICIAL INTELLIGENCE (AI)
AI in gastroenterology is evolving from standalone tools to real-time, cloud-connected intelligence embedded directly into procedures. Odin Vision, now part…
Tech & Innovation
With GI cancers expected to double globally by 2050 and colorectal cancer rising among younger adults, clinicians are exploring new technologies to improve detection and treatment.…
Editor's Picks
Helio Genomics and Quest Diagnostics have partnered to expand access to a…
Business
Abbott’s acquisition of Exact Sciences isn’t just a portfolio expansion—it’s a strategic…
Exponential Tech
With GI cancers expected to double globally by 2050 and colorectal cancer…
Leadership
Gastroenterologists face rising clinical and operational obstacles as the GI diseases become…
Patient Trends
A new population-based study published in Clinical Gastroenterology and Hepatology evaluated the…
